EUVIMEDEUVIMED entdecken
Crossref

“Pseudosubstrate Envelope”/Free Energy Perturbation-Guided Design and Mechanistic Investigations of Benzothiazole HIV Capsid Modulators with High Ligand Efficiency

Shujing Xu, Shuo Wang, Yang Zhou, Nicholas Foley, Lin Sun iD, Laura Walsham iD, Kai Tang, Dazhou Shi, Xiaoyu Shi, Zhijiao Zhang, Xiangyi Jiang, Shenghua Gao und 5 weitere

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Shujing Xu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University…. Hauptthemen laut MEDLINE: Anti-HIV Agents, Benzothiazoles, Capsid Proteins, Drug Design. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Institute of Neurological Disorders and Stroke, Ministry of Science and Technology of the People's Republic of China, Wallace H. Coulter Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Based on our proposed "pseudosubstrate envelope" concept, 25 benzothiazole-bearing HIV capsid protein (CA) modulators were designed and synthesized under the guidance of free energy perturbation technology. The most potent compound, IC-1k, exhibited an EC50 of 2.69 nM against HIV-1, being 393 times more potent than the positive control PF74. Notably, IC-1k emerged as the highest ligand efficiency (LE = 0.32) HIV CA modulator, surpassing that of the approved drug lenacapavir (LE = 0.21). Surface plasmon resonance assay and crystallographic analysis confirmed that IC-1k targeted HIV-1 CA within the chemical space of the "pseudosubstrate envelope". Further mechanistic studies revealed a dual-stage inhibition profile: IC-1k disrupted early-stage capsid-host-factor interactions and promoted late-stage capsid misassembly. Preliminary pharmacokinetic evaluations demonstrated significantly improved metabolic stability in human liver microsomes for IC-1k (T1/2 = 91.3 min) compared to PF74 (T1/2 = 0.7 min), alongside a favorable safety profile. Overall, IC-1k presents a promising lead compound for further optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsBenzothiazolesCapsid ProteinsDrug DesignHIV-1HumansLigandsMicrosomes, LiverStructure-Activity RelationshipThermodynamicsAcetamidesIndazoles

Substanzen

Anti-HIV AgentsbenzothiazoleBenzothiazolesCapsid ProteinsLigandslenacapavirAcetamidesIndazoles

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan, Shandong 250012, PR China.
  • Department of Biochemistry & Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States.
  • School of Biological Sciences, The University of Auckland, 3A Symonds Street, Auckland 1010, New Zealand.
  • Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, K.U. Leuven, Herestraat 49 Postbus 1043 (09.A097), Leuven B-3000, Belgium.

ORCID-Profile: Lin Sun, Laura Walsham, Xinyong Liu, David C Goldstone, Peng Zhan

Förderung

  • National Institute of Neurological Disorders and Stroke
  • Ministry of Science and Technology of the People's Republic of China
  • Wallace H. Coulter Foundation
  • National Institute of Allergy and Infectious Diseases
  • National Natural Science Foundation of China
  • Shandong Laboratory Program

Zitieren

APA

Xu, S., Wang, S., Zhou, Y., Foley, N., Sun, L., Walsham, L., Tang, K., Shi, D., Shi, X., Zhang, Z., Jiang, X., Gao, S., Liu, X., Pannecouque, C., Goldstone, D. C., Dick, A., & Zhan, P. (2024). “Pseudosubstrate Envelope”/Free Energy Perturbation-Guided Design and Mechanistic Investigations of Benzothiazole HIV Capsid Modulators with High Ligand Efficiency. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01544

Vancouver

Xu S, Wang S, Zhou Y, Foley N, Sun L, Walsham L, et al. “Pseudosubstrate Envelope”/Free Energy Perturbation-Guided Design and Mechanistic Investigations of Benzothiazole HIV Capsid Modulators with High Ligand Efficiency. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01544

BibTeX
@article{Xu2024,
  author = {Xu, Shujing and Wang, Shuo and Zhou, Yang and Foley, Nicholas and Sun, Lin and Walsham, Laura and Tang, Kai and Shi, Dazhou and Shi, Xiaoyu and Zhang, Zhijiao and Jiang, Xiangyi and Gao, Shenghua and Liu, Xinyong and Pannecouque, Christophe and Goldstone, David C and Dick, Alexej and Zhan, Peng},
  title = {“Pseudosubstrate Envelope”/Free Energy Perturbation-Guided Design and Mechanistic Investigations of Benzothiazole HIV Capsid Modulators with High Ligand Efficiency},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01544}
}
Kostenlos starten →